Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Study examines how EHR data can identify patients' fall risk

Repurposed EHR data collected during office visits can identify patient risk factors and prevent unintentional falls in seniors, according to findings published in Perspectives in Health Information Management, the online research journal of the American Health Information Management Association (AHIMA).

Thumbnail

CMS delays new rating system at the 11th hour

The Centers for Medicare & Medicaid Services has caved to pressure from Congress and the healthcare industry, delaying the release of its new hospital quality rating measure a day before its planned launch.

Value-based payment models drive physicians to use EHRs to improve care

Physicians who use EHRs and are in accountable care organizations or patient-centered medical homes are more likely to use care coordination, quality measurement, patient engagement and population health management strategies, according to a study published in the American Journal of Managed Care. 

AHIMA's IG pilot participants offer lessons learned

The healthcare organizations that began taking part in AHIMA’s information governance (IG) pilot program are ready to offer several best practices and critical success factors. 

Federal audit finds $10 million wasted in Oregon Medicaid

A Health and Human Services audit of Oregon’s Medicaid program found $10 million in waste in 2014.

IBM's new Health Corps to connect tech with public health initiatives around the globe

IBM unveiled its new corporate citizenship program called the IBM Health Corps, which will bring IBM's top talent and cognitive technologies to help communities address health challenges such as primary care gaps, health worker shortages and access to safe water and nutritious food.

U.S. drug spending climbs 12 percent in 2015

Total spending on prescription drugs in the U.S. rose 12.2 percent to nearly $425 billion in 2015, continuing a steep climb fueled by the introduction in recent years of expensive new drugs for cancer and infections, as well as price hikes for older drugs, according to The Wall Street Journal.

States poised to take the lead on healthcare cost control

A new report from the Center for American Progress outlines how states are well-positioned to be leaders in implementing policies to help control health care costs and improve quality. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.